Shu Y - Search Results

1

miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.

Zhu W, Xu H, Zhu D, Zhi H, Wang T, Wang J, Jiang B, Shu Y, Liu P. Zhu W, et al. Among authors: shu y. Cancer Chemother Pharmacol. 2012 Mar;69(3):723-31. doi: 10.1007/s00280-011-1752-3. Epub 2011 Oct 13. Cancer Chemother Pharmacol. 2012. PMID: 21993663

2

Paeoniflorin suppress NF-kappaB activation through modulation of I kappaB alpha and enhances 5-fluorouracil-induced apoptosis in human gastric carcinoma cells.

Wu H, Li W, Wang T, Shu Y, Liu P. Wu H, et al. Among authors: shu y. Biomed Pharmacother. 2008 Nov;62(9):659-66. doi: 10.1016/j.biopha.2008.08.002. Epub 2008 Aug 31. Biomed Pharmacother. 2008. PMID: 18809274

3

Promoter polymorphisms of IL2, IL4, and risk of gastric cancer in a high-risk Chinese population.

Wu J, Lu Y, Ding YB, Ke Q, Hu ZB, Yan ZG, Xue Y, Zhou Y, Hua ZL, Shu YQ, Liu P, Shen J, Xu YC, Shen HB. Wu J, et al. Among authors: shu yq. Mol Carcinog. 2009 Jul;48(7):626-32. doi: 10.1002/mc.20502. Mol Carcinog. 2009. PMID: 19058298

4

A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese.

Tian T, Shu Y, Chen J, Hu Z, Xu L, Jin G, Liang J, Liu P, Zhou X, Miao R, Ma H, Chen Y, Shen H. Tian T, et al. Among authors: shu y. Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1183-7. doi: 10.1158/1055-9965.EPI-08-0814. Epub 2009 Mar 17. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19293314

5

Involvement of mTOR and survivin inhibition in tamoxifen-induced apoptosis in human hepatoblastoma cell line HepG2.

Guo R, Wang T, Shen H, Ge HM, Sun J, Huang ZH, Shu YQ. Guo R, et al. Biomed Pharmacother. 2010 Apr;64(4):249-53. doi: 10.1016/j.biopha.2009.06.007. Epub 2009 Oct 22. Biomed Pharmacother. 2010. PMID: 19931998

6

Genetic variation of PSCA gene is associated with the risk of both diffuse- and intestinal-type gastric cancer in a Chinese population.

Lu Y, Chen J, Ding Y, Jin G, Wu J, Huang H, Deng B, Hua Z, Zhou Y, Shu Y, Liu P, Hu Z, Shen J, Xu Y, Shen H. Lu Y, et al. Among authors: shu y. Int J Cancer. 2010 Nov 1;127(9):2183-9. doi: 10.1002/ijc.25228. Int J Cancer. 2010. PMID: 20131315

7

miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines.

Zhu W, Shan X, Wang T, Shu Y, Liu P. Zhu W, et al. Among authors: shu y. Int J Cancer. 2010 Dec 1;127(11):2520-9. doi: 10.1002/ijc.25260. Int J Cancer. 2010. PMID: 20162574

8

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.

Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y. Gao W, et al. Among authors: shu y. Biomed Pharmacother. 2010 Jul;64(6):399-408. doi: 10.1016/j.biopha.2010.01.018. Epub 2010 Feb 25. Biomed Pharmacother. 2010. PMID: 20363096

9

MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis.

Gao W, Shen H, Liu L, Xu J, Xu J, Shu Y. Gao W, et al. Among authors: shu y. J Cancer Res Clin Oncol. 2011 Apr;137(4):557-66. doi: 10.1007/s00432-010-0918-4. Epub 2010 May 28. J Cancer Res Clin Oncol. 2011. PMID: 20508945

10

[Clinical Study of Erlotinib in the Treatment of Patients with Advanced Stage Non-small Cell Lung Cancer.].

Wang T, Sun J, Gao W, Shen H, Li X, Yin Y, Shu Y, Guo R. Wang T, et al. Among authors: shu y. Zhongguo Fei Ai Za Zhi. 2009 Dec 20;12(12):1287-90. doi: 10.3779/j.issn.1009-3419.2009.12.12. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20723385 Free article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,928 results

Search Page

Filters